Geode Capital Management LLC Buys 3,960 Shares of Harrow, Inc. (NASDAQ:HROW)

Geode Capital Management LLC raised its stake in shares of Harrow, Inc. (NASDAQ:HROW) by 0.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 722,730 shares of the company’s stock after buying an additional 3,960 shares during the quarter. Geode Capital Management LLC owned about 2.04% of Harrow worth $32,500,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Quest Partners LLC bought a new stake in Harrow in the third quarter valued at approximately $29,000. nVerses Capital LLC bought a new stake in shares of Harrow in the 2nd quarter valued at $33,000. Allspring Global Investments Holdings LLC raised its stake in Harrow by 2,730.7% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,123 shares of the company’s stock worth $44,000 after buying an additional 2,048 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Harrow by 21.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,283 shares of the company’s stock worth $57,000 after acquiring an additional 227 shares in the last quarter. Finally, Hills Bank & Trust Co acquired a new position in Harrow in the third quarter valued at about $107,000. 72.76% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

HROW has been the topic of a number of research analyst reports. Lake Street Capital raised their price target on Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a research report on Friday, October 4th. Craig Hallum raised their target price on shares of Harrow from $45.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, October 4th. Finally, B. Riley dropped their price objective on shares of Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a report on Wednesday, December 4th.

Harrow Price Performance

Shares of HROW opened at $33.83 on Thursday. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 3.23. Harrow, Inc. has a twelve month low of $9.13 and a twelve month high of $59.23. The stock has a market capitalization of $1.20 billion, a P/E ratio of -35.99 and a beta of 0.69. The company has a 50 day moving average of $43.82 and a 200-day moving average of $37.01.

Harrow Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.